CD40 in coronary artery disease: a matter of macrophages?

被引:0
|
作者
Matthijs F. Jansen
Maurits R. Hollander
Niels van Royen
Anton J. Horrevoets
Esther Lutgens
机构
[1] VU University Medical Centre,Department of Molecular Cell Biology and Immunology
[2] Academic Medical Centre,Department of Medical Biochemistry
[3] VU University Medical Center,Department of Cardiology
[4] Ludwig Maximilians University,Institute for Cardiovascular Prevention (IPEK)
来源
关键词
CD40; Macrophage; Atherosclerosis; Arteriogenesis; Neointima formation; Ischemic heart disease;
D O I
暂无
中图分类号
学科分类号
摘要
Coronary artery disease (CAD), also known as ischemic heart disease (IHD), is the leading cause of mortality in the western world, with developing countries showing a similar trend. With the increased understanding of the role of the immune system and inflammation in coronary artery disease, it was shown that macrophages play a major role in this disease. Costimulatory molecules are important regulators of inflammation, and especially, the CD40L-CD40 axis is of importance in the pathogenesis of cardiovascular disease. Although it was shown that CD40 can mediate macrophage function, its exact role in macrophage biology has not gained much attention in cardiovascular disease. Therefore, the goal of this review is to give an overview on the role of macrophage-specific CD40 in cardiovascular disease, with a focus on coronary artery disease. We will discuss the function of CD40 on the macrophage and its (proposed) role in the reduction of atherosclerosis, the reduction of neointima formation, and the stimulation of arteriogenesis.
引用
收藏
相关论文
共 50 条
  • [41] CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease
    Tanne, D
    Haim, M
    Goldbourt, U
    Boyko, V
    Reshef, T
    Adler, Y
    Benderly, M
    Mekori, YA
    Behar, S
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 107 (03) : 322 - 326
  • [42] The use of MCP-1 and soluble CD40 ligand in a pathophysiology-guided approach to the management of coronary artery disease
    Mo, Vivian Y.
    de Lemos, James A.
    [J]. FUTURE CARDIOLOGY, 2005, 1 (05) : 649 - 656
  • [43] In situ expression of CD40 and CD40 ligand in psoriasis
    Ohta, Y
    Hamada, Y
    [J]. DERMATOLOGY, 2004, 209 (01) : 21 - 28
  • [44] Soluble CD40 ligand in predicting coronary artery disease and long-term outcomes in stable patients with angiographically defined disease states
    Lappe, JM
    Carlquist, JF
    Anderson, JL
    Kolek, MJ
    Horne, BD
    Whiting, BM
    Jones, HU
    Pearson, RR
    Walker, J
    Muhlestein, JB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 297A - 298A
  • [45] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    [J]. CIRCULATION, 2015, 131
  • [46] Role of the CD40 locus in Graves' disease
    Houston, FA
    Wilson, V
    Jennings, CE
    Owen, CJ
    Donaldson, P
    Perros, P
    Pearce, SHS
    [J]. THYROID, 2004, 14 (07) : 506 - 509
  • [47] The Role Of CD40L And CD40 In The Pathogenesis Of Kawasaki Disease
    Parsaud, Leon
    Arjmand, Parnian
    Duong, Trang T.
    Yeung, Rae S.
    [J]. CIRCULATION, 2015, 131
  • [48] CD40/CD40 interactions required for EAU.
    Bagenstose, LM
    Silver, P
    Hoffman, SC
    Kampen, RL
    Chan, CC
    Wiggert, B
    Harlan, DM
    Caspi, R
    [J]. CLINICAL IMMUNOLOGY, 2002, 103 (03) : S53 - S53
  • [49] Irradiation of CD40 and CD40L in inflammatory liver disease
    Leifeld, L
    Dumoulin, FL
    Ramakers, J
    Wolff, M
    Sauerbruch, T
    Spengler, U
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1318 - A1318
  • [50] CD40 ligand gene and Kawasaki disease
    Onouchi, Y
    Onoue, S
    Tamari, M
    Wakui, K
    Fukushima, Y
    Yashiro, M
    Nakamura, Y
    Yanagawa, H
    Kishi, F
    Ouchi, K
    Terai, M
    Hamamoto, K
    Kudo, F
    Aotsuka, H
    Sato, Y
    Nariai, A
    Kaburagi, Y
    Miura, M
    Saji, T
    Kawasaki, T
    Nakamura, Y
    Hata, A
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (12) : 1062 - 1068